Low dose hyper-radiosensitivity

A historical perspective

Brian Marples, Sarah A. Krueger, Spencer J. Collis, Michael C. Joiner

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

This chapter discusses the biology of low-dose hyper-radiosensitivity (HRS) with reference to radiation-induced DNA damage and cellular repair processes. Particular attention is paid to the significance of G2-phase cell cycle check-points in overcoming low-dose hyper-radiosensitivity and the impact of HRS on low-dose rate radiobiology. The history of HRS from the original in vivo discovery to the most recent in vitro and clinical data are examined to present a unifying hypothesis concerning the molecular control and regulation of this important low-dose radiation response. Finally, pre-clinical and clinical data are discussed, from a molecular viewpoint, to provide theoretical approaches to exploit HRS biology for clinical gain.

Original languageEnglish (US)
Title of host publicationTargeted Radionuclide Tumor Therapy
Subtitle of host publicationBiological Aspects
PublisherSpringer Netherlands
Pages329-347
Number of pages19
ISBN (Print)9781402086953
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

Radiation Tolerance
Radiation
Radiobiology
G2 Phase
DNA Damage
Cell Cycle
History

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Marples, B., Krueger, S. A., Collis, S. J., & Joiner, M. C. (2008). Low dose hyper-radiosensitivity: A historical perspective. In Targeted Radionuclide Tumor Therapy: Biological Aspects (pp. 329-347). Springer Netherlands. https://doi.org/10.1007/978-1-4020-8696-0_19

Low dose hyper-radiosensitivity : A historical perspective. / Marples, Brian; Krueger, Sarah A.; Collis, Spencer J.; Joiner, Michael C.

Targeted Radionuclide Tumor Therapy: Biological Aspects. Springer Netherlands, 2008. p. 329-347.

Research output: Chapter in Book/Report/Conference proceedingChapter

Marples, B, Krueger, SA, Collis, SJ & Joiner, MC 2008, Low dose hyper-radiosensitivity: A historical perspective. in Targeted Radionuclide Tumor Therapy: Biological Aspects. Springer Netherlands, pp. 329-347. https://doi.org/10.1007/978-1-4020-8696-0_19
Marples B, Krueger SA, Collis SJ, Joiner MC. Low dose hyper-radiosensitivity: A historical perspective. In Targeted Radionuclide Tumor Therapy: Biological Aspects. Springer Netherlands. 2008. p. 329-347 https://doi.org/10.1007/978-1-4020-8696-0_19
Marples, Brian ; Krueger, Sarah A. ; Collis, Spencer J. ; Joiner, Michael C. / Low dose hyper-radiosensitivity : A historical perspective. Targeted Radionuclide Tumor Therapy: Biological Aspects. Springer Netherlands, 2008. pp. 329-347
@inbook{6f6701daeb384e348f7643e94b14abef,
title = "Low dose hyper-radiosensitivity: A historical perspective",
abstract = "This chapter discusses the biology of low-dose hyper-radiosensitivity (HRS) with reference to radiation-induced DNA damage and cellular repair processes. Particular attention is paid to the significance of G2-phase cell cycle check-points in overcoming low-dose hyper-radiosensitivity and the impact of HRS on low-dose rate radiobiology. The history of HRS from the original in vivo discovery to the most recent in vitro and clinical data are examined to present a unifying hypothesis concerning the molecular control and regulation of this important low-dose radiation response. Finally, pre-clinical and clinical data are discussed, from a molecular viewpoint, to provide theoretical approaches to exploit HRS biology for clinical gain.",
author = "Brian Marples and Krueger, {Sarah A.} and Collis, {Spencer J.} and Joiner, {Michael C.}",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/978-1-4020-8696-0_19",
language = "English (US)",
isbn = "9781402086953",
pages = "329--347",
booktitle = "Targeted Radionuclide Tumor Therapy",
publisher = "Springer Netherlands",

}

TY - CHAP

T1 - Low dose hyper-radiosensitivity

T2 - A historical perspective

AU - Marples, Brian

AU - Krueger, Sarah A.

AU - Collis, Spencer J.

AU - Joiner, Michael C.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - This chapter discusses the biology of low-dose hyper-radiosensitivity (HRS) with reference to radiation-induced DNA damage and cellular repair processes. Particular attention is paid to the significance of G2-phase cell cycle check-points in overcoming low-dose hyper-radiosensitivity and the impact of HRS on low-dose rate radiobiology. The history of HRS from the original in vivo discovery to the most recent in vitro and clinical data are examined to present a unifying hypothesis concerning the molecular control and regulation of this important low-dose radiation response. Finally, pre-clinical and clinical data are discussed, from a molecular viewpoint, to provide theoretical approaches to exploit HRS biology for clinical gain.

AB - This chapter discusses the biology of low-dose hyper-radiosensitivity (HRS) with reference to radiation-induced DNA damage and cellular repair processes. Particular attention is paid to the significance of G2-phase cell cycle check-points in overcoming low-dose hyper-radiosensitivity and the impact of HRS on low-dose rate radiobiology. The history of HRS from the original in vivo discovery to the most recent in vitro and clinical data are examined to present a unifying hypothesis concerning the molecular control and regulation of this important low-dose radiation response. Finally, pre-clinical and clinical data are discussed, from a molecular viewpoint, to provide theoretical approaches to exploit HRS biology for clinical gain.

UR - http://www.scopus.com/inward/record.url?scp=84892122569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892122569&partnerID=8YFLogxK

U2 - 10.1007/978-1-4020-8696-0_19

DO - 10.1007/978-1-4020-8696-0_19

M3 - Chapter

SN - 9781402086953

SP - 329

EP - 347

BT - Targeted Radionuclide Tumor Therapy

PB - Springer Netherlands

ER -